BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26796063)

  • 21. Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines.
    Wu CP; Hung CY; Lusvarghi S; Huang YH; Tseng PJ; Hung TH; Yu JS; Ambudkar SV
    Biochem Pharmacol; 2020 Oct; 180():114137. PubMed ID: 32634436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human ATP-binding cassette transporters ABCB1 and ABCG2 confer resistance to histone deacetylase 6 inhibitor ricolinostat (ACY-1215) in cancer cell lines.
    Wu CP; Hsieh YJ; Murakami M; Vahedi S; Hsiao SH; Yeh N; Chou AW; Li YQ; Wu YS; Yu JS; Ambudkar SV
    Biochem Pharmacol; 2018 Sep; 155():316-325. PubMed ID: 30028995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A-803467, a tetrodotoxin-resistant sodium channel blocker, modulates ABCG2-mediated MDR in vitro and in vivo.
    Anreddy N; Patel A; Zhang YK; Wang YJ; Shukla S; Kathawala RJ; Kumar P; Gupta P; Ambudkar SV; Wurpel JN; Chen ZS; Guo H
    Oncotarget; 2015 Nov; 6(36):39276-91. PubMed ID: 26515463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo.
    Wang XK; To KK; Huang LY; Xu JH; Yang K; Wang F; Huang ZC; Ye S; Fu LW
    Oncotarget; 2014 Dec; 5(23):11971-85. PubMed ID: 25436978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines.
    Wu CP; Hsiao SH; Murakami M; Lu MJ; Li YQ; Hsieh CH; Ambudkar SV; Wu YS
    Cancer Lett; 2017 Nov; 409():56-65. PubMed ID: 28893612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.
    Zhu MM; Tong JL; Xu Q; Nie F; Xu XT; Xiao SD; Ran ZH
    PLoS One; 2012; 7(8):e41763. PubMed ID: 22870247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human ATP-Binding Cassette Transporter ABCB1 Confers Resistance to Volasertib (BI 6727), a Selective Inhibitor of Polo-like Kinase 1.
    Wu CP; Hsieh CH; Hsiao SH; Luo SY; Su CY; Li YQ; Huang YH; Huang CW; Hsu SC
    Mol Pharm; 2015 Nov; 12(11):3885-95. PubMed ID: 26412161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter.
    Qiu JG; Zhang YJ; Li Y; Zhao JM; Zhang WJ; Jiang QW; Mei XL; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Shi Z
    Oncotarget; 2015 Jun; 6(17):15494-509. PubMed ID: 25915534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport.
    Patel A; Li TW; Anreddy N; Wang DS; Sodani K; Gadhia S; Kathawala R; Yang DH; Cheng C; Chen ZS
    Pharmacol Res; 2017 Jul; 121():184-193. PubMed ID: 28455266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of phosphoinositide-3 kinase pathway down regulates ABCG2 function and sensitizes malignant pleural mesothelioma to chemotherapy.
    Fischer B; Frei C; Moura U; Stahel R; Felley-Bosco E
    Lung Cancer; 2012 Oct; 78(1):23-9. PubMed ID: 22857894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma.
    Mondello P; Derenzini E; Asgari Z; Philip J; Brea EJ; Seshan V; Hendrickson RC; de Stanchina E; Scheinberg DA; Younes A
    Oncotarget; 2017 Feb; 8(8):14017-14028. PubMed ID: 28147336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.
    Wu CP; Li YQ; Chi YC; Huang YH; Hung TH; Wu YS
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of ABCG2 confers resistance to pevonedistat, an NAE inhibitor.
    Wei LY; Wu ZX; Yang Y; Zhao M; Ma XY; Li JS; Yang DH; Chen ZS; Fan YF
    Exp Cell Res; 2020 Mar; 388(2):111858. PubMed ID: 31972220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CUDC-907 Promotes Bone Marrow Adipocytic Differentiation Through Inhibition of Histone Deacetylase and Regulation of Cell Cycle.
    Ali D; Alshammari H; Vishnubalaji R; Chalisserry EP; Hamam R; Alfayez M; Kassem M; Aldahmash A; Alajez NM
    Stem Cells Dev; 2017 Mar; 26(5):353-362. PubMed ID: 27829312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach.
    Ranganna K; Selvam C; Shivachar A; Yousefipour Z
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms.
    Wang Y; Wen J; Sun X; Sun Y; Liu Y; Cheng X; Wu W; Liu Q; Ren F
    Cancer Chemother Pharmacol; 2024 Apr; 93(4):295-306. PubMed ID: 37938423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters.
    Zhang YK; Zhang GN; Wang YJ; Patel BA; Talele TT; Yang DH; Chen ZS
    Sci Rep; 2016 May; 6():25694. PubMed ID: 27157787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter.
    Hegedüs C; Truta-Feles K; Antalffy G; Brózik A; Kasza I; Német K; Orbán TI; Özvegy-Laczka C; Váradi A; Sarkadi B
    Biochem Biophys Res Commun; 2012 Apr; 420(4):869-74. PubMed ID: 22449574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.
    Wu CP; Lusvarghi S; Wang JC; Hsiao SH; Huang YH; Hung TH; Ambudkar SV
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat.
    Wu CP; Hung CY; Lusvarghi S; Chang YF; Hsiao SH; Huang YH; Hung TH; Yu JS; Ambudkar SV
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.